-
CheckOrphan NewsFlash, March 2,…
3/02/2010
CheckOrphan NewsFlash for Tuesday, March 2, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash January 15,…
1/15/2010
CheckOrphan NewsFlash for Friday, January 15, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash January 11,…
1/11/2010
CheckOrphan NewsFlash for Monday, January 11, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
Interdisciplinary Training…
15–16 March, 2010
The goal of this meeting is to mentor the career development of a “…
-
ICORD 2010: Sixth International…
18–20 March, 2010
The VI International Conference on Rare Diseases and Orphan Drugs (ICORD…
-
Improving Musculoskeletal Outcomes…
7–9 April, 2010
The goals of this workshop are to (1) assess the state of knowledge…
-
Third NIH Workshop on Gaucher…
8–9 April, 2010
Workshop goals are to (1) determine the appropriate human, animal, or cell…
Events
-
The Sea Squirt Offers Hope for Alzheimer's Sufferers
Tuesday, March 2, 2010
Alzheimer's disease affects an estimated 27 million people worldwideIt is the most common form of age-related dementia, possibly the most feared disease of old age. There is no cure, and the available drugs only help to relieve symptoms without slowing progression of the disease. One of the charac
-
Targeted Delivery of Losartan Reduces Liver Inflammation and Scarring
Monday, March 1, 2010
A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosisThose animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in th
-
Ghrelin Mitigates Liver Fibrosis in Animal Models, Regulates Human Fibrosis
Monday, March 1, 2010
Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosisGhrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stre
-
Gene Signature May Improve Colon Cancer Treatment
Monday, March 1, 2010
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchersThe findings, published in the March issue of Gastroenterology, could help personalize treatments
-
Gene Therapy Reverses Effects of Lethal Childhood Muscle Disease in Mice
Monday, March 1, 2010
COLUMBUS, Ohio -- Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research showsThis muscle-wasting disease results when a child&r
-
New Study Casts Doubt Over ME Virus Link
Friday, February 26, 2010
A new study published on bmj.com today casts doubt on recent claims that a human retrovirus known as XMRV is linked to chronic fatigue syndrome or ME (myalgic encephalitisThis is the third study to refute the original US study reporting the linkChronic fatigue syndrome is a debilitating condition
-
Multiple Sclerosis, Italian Researchers Discover a Possible Onset Mechanism for the Disease
Friday, February 26, 2010
A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work. This is what a group of researchers from the Catholic University of Rome, led by Francesco Ria (Institute of Multi
-
MeCP2 Goes Global -- Redefining the Function of the Rett Syndrome Protein
Friday, February 26, 2010
A paper published online today in Molecular Cell proposes that Methyl CpG binding protein 2 (MeCP2) impacts the entire genome in neurons, rather than acting as a regulator of specific genesMutations in MeCP2 cause the autism spectrum disorder Rett Syndrome as well as some cases of neuropsychiatric
-
New Strategy Develops 2 Prototype Drugs Against Cancer, Retinal Diseases
Friday, February 26, 2010
HOUSTON -- A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University
-
Emerging Tick-Borne Disease
Friday, February 26, 2010
Stories of environmental damage and their consequences always seem to take place far away and in another country, usually a tropical one with lush rainforests and poison dart frogsIn fact, similar stories starring familiar animals are unfolding all the time in our own backyards — including g
